UniProt ID | AATM_HUMAN | |
---|---|---|
UniProt AC | P00505 | |
Protein Name | Aspartate aminotransferase, mitochondrial | |
Gene Name | GOT2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 430 | |
Subcellular Localization | Mitochondrion matrix . Cell membrane . Exposure to alcohol promotes translocation to the cell membrane. | |
Protein Description | Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). Plays a key role in amino acid metabolism. Important for metabolite exchange between mitochondria and cytosol. Facilitates cellular uptake of long-chain free fatty acids.. | |
Protein Sequence | MALLHSGRVLPGIAAAFHPGLAAAASARASSWWTHVEMGPPDPILGVTEAFKRDTNSKKMNLGVGAYRDDNGKPYVLPSVRKAEAQIAAKNLDKEYLPIGGLAEFCKASAELALGENSEVLKSGRFVTVQTISGTGALRIGASFLQRFFKFSRDVFLPKPTWGNHTPIFRDAGMQLQGYRYYDPKTCGFDFTGAVEDISKIPEQSVLLLHACAHNPTGVDPRPEQWKEIATVVKKRNLFAFFDMAYQGFASGDGDKDAWAVRHFIEQGINVCLCQSYAKNMGLYGERVGAFTMVCKDADEAKRVESQLKILIRPMYSNPPLNGARIAAAILNTPDLRKQWLQEVKVMADRIIGMRTQLVSNLKKEGSTHNWQHITDQIGMFCFTGLKPEQVERLIKEFSIYMTKDGRISVAGVTSSNVGYLAHAIHQVTK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
48 | Phosphorylation | PDPILGVTEAFKRDT CCCCCCHHHHHHCCC | 21.57 | 24275569 | |
52 | Acetylation | LGVTEAFKRDTNSKK CCHHHHHHCCCCCCC | 57.31 | 30582669 | |
59 | 2-Hydroxyisobutyrylation | KRDTNSKKMNLGVGA HCCCCCCCCEEEEEE | 32.61 | - | |
59 | Acetylation | KRDTNSKKMNLGVGA HCCCCCCCCEEEEEE | 32.61 | - | |
59 | Malonylation | KRDTNSKKMNLGVGA HCCCCCCCCEEEEEE | 32.61 | 26320211 | |
59 | Succinylation | KRDTNSKKMNLGVGA HCCCCCCCCEEEEEE | 32.61 | 27452117 | |
59 | Ubiquitination | KRDTNSKKMNLGVGA HCCCCCCCCEEEEEE | 32.61 | 24816145 | |
67 | Phosphorylation | MNLGVGAYRDDNGKP CEEEEEEEECCCCCC | 14.51 | - | |
73 | Acetylation | AYRDDNGKPYVLPSV EEECCCCCCCCCCCH | 39.16 | - | |
73 | Acetylation | AYRDDNGKPYVLPSV EEECCCCCCCCCCCH | 39.16 | 19608861 | |
73 | Malonylation | AYRDDNGKPYVLPSV EEECCCCCCCCCCCH | 39.16 | 26320211 | |
73 | Succinylation | AYRDDNGKPYVLPSV EEECCCCCCCCCCCH | 39.16 | - | |
73 | Succinylation | AYRDDNGKPYVLPSV EEECCCCCCCCCCCH | 39.16 | 27452117 | |
73 | Ubiquitination | AYRDDNGKPYVLPSV EEECCCCCCCCCCCH | 39.16 | 24816145 | |
75 | Phosphorylation | RDDNGKPYVLPSVRK ECCCCCCCCCCCHHH | 20.36 | 28152594 | |
79 | Phosphorylation | GKPYVLPSVRKAEAQ CCCCCCCCHHHHHHH | 30.32 | 28152594 | |
82 | 2-Hydroxyisobutyrylation | YVLPSVRKAEAQIAA CCCCCHHHHHHHHHH | 48.71 | - | |
82 | Acetylation | YVLPSVRKAEAQIAA CCCCCHHHHHHHHHH | 48.71 | - | |
82 | Malonylation | YVLPSVRKAEAQIAA CCCCCHHHHHHHHHH | 48.71 | 26320211 | |
82 | Succinylation | YVLPSVRKAEAQIAA CCCCCHHHHHHHHHH | 48.71 | 27452117 | |
82 | Ubiquitination | YVLPSVRKAEAQIAA CCCCCHHHHHHHHHH | 48.71 | 29967540 | |
90 | 2-Hydroxyisobutyrylation | AEAQIAAKNLDKEYL HHHHHHHHCCCCCCC | 49.36 | - | |
90 | Acetylation | AEAQIAAKNLDKEYL HHHHHHHHCCCCCCC | 49.36 | 19608861 | |
90 | Malonylation | AEAQIAAKNLDKEYL HHHHHHHHCCCCCCC | 49.36 | 26320211 | |
90 | Succinylation | AEAQIAAKNLDKEYL HHHHHHHHCCCCCCC | 49.36 | - | |
90 | Succinylation | AEAQIAAKNLDKEYL HHHHHHHHCCCCCCC | 49.36 | - | |
90 | Ubiquitination | AEAQIAAKNLDKEYL HHHHHHHHCCCCCCC | 49.36 | 27667366 | |
94 | 2-Hydroxyisobutyrylation | IAAKNLDKEYLPIGG HHHHCCCCCCCCCCH | 51.96 | - | |
94 | Acetylation | IAAKNLDKEYLPIGG HHHHCCCCCCCCCCH | 51.96 | 25825284 | |
94 | Ubiquitination | IAAKNLDKEYLPIGG HHHHCCCCCCCCCCH | 51.96 | 22817900 | |
96 | Nitrated tyrosine | AKNLDKEYLPIGGLA HHCCCCCCCCCCHHH | 24.42 | - | |
96 | Nitration | AKNLDKEYLPIGGLA HHCCCCCCCCCCHHH | 24.42 | - | |
96 | Phosphorylation | AKNLDKEYLPIGGLA HHCCCCCCCCCCHHH | 24.42 | 27155012 | |
106 | Glutathionylation | IGGLAEFCKASAELA CCHHHHHHHHHHHHH | 2.44 | 22555962 | |
107 | Acetylation | GGLAEFCKASAELAL CHHHHHHHHHHHHHH | 51.18 | 25038526 | |
107 | Succinylation | GGLAEFCKASAELAL CHHHHHHHHHHHHHH | 51.18 | - | |
107 | Succinylation | GGLAEFCKASAELAL CHHHHHHHHHHHHHH | 51.18 | - | |
107 | Ubiquitination | GGLAEFCKASAELAL CHHHHHHHHHHHHHH | 51.18 | 21963094 | |
109 | Phosphorylation | LAEFCKASAELALGE HHHHHHHHHHHHHCC | 14.05 | 25072903 | |
116 | Acetylation | SAELALGENSEVLKS HHHHHHCCCCHHHHC | 59.44 | - | |
116 | Acetylation | SAELALGENSEVLKS HHHHHHCCCCHHHHC | 59.44 | 19608861 | |
118 | Phosphorylation | ELALGENSEVLKSGR HHHHCCCCHHHHCCC | 25.44 | 23911959 | |
122 | 2-Hydroxyisobutyrylation | GENSEVLKSGRFVTV CCCCHHHHCCCEEEE | 56.91 | - | |
122 | Acetylation | GENSEVLKSGRFVTV CCCCHHHHCCCEEEE | 56.91 | 23954790 | |
122 | Malonylation | GENSEVLKSGRFVTV CCCCHHHHCCCEEEE | 56.91 | 26320211 | |
122 | Succinylation | GENSEVLKSGRFVTV CCCCHHHHCCCEEEE | 56.91 | - | |
122 | Succinylation | GENSEVLKSGRFVTV CCCCHHHHCCCEEEE | 56.91 | - | |
122 | Ubiquitination | GENSEVLKSGRFVTV CCCCHHHHCCCEEEE | 56.91 | 22817900 | |
128 | Phosphorylation | LKSGRFVTVQTISGT HHCCCEEEEEEECCC | 12.27 | 18491316 | |
131 | Phosphorylation | GRFVTVQTISGTGAL CCEEEEEEECCCCHH | 16.87 | 25867546 | |
133 | Phosphorylation | FVTVQTISGTGALRI EEEEEEECCCCHHHH | 33.42 | 28857561 | |
135 | Phosphorylation | TVQTISGTGALRIGA EEEEECCCCHHHHCH | 16.70 | 18491316 | |
142 | Acetylation | TGALRIGASFLQRFF CCHHHHCHHHHHHHH | 8.50 | - | |
142 | Ubiquitination | TGALRIGASFLQRFF CCHHHHCHHHHHHHH | 8.50 | 29967540 | |
143 | Phosphorylation | GALRIGASFLQRFFK CHHHHCHHHHHHHHH | 22.67 | 30266825 | |
150 | Acetylation | SFLQRFFKFSRDVFL HHHHHHHHHCCCCCC | 39.45 | 25825284 | |
150 | Methylation | SFLQRFFKFSRDVFL HHHHHHHHHCCCCCC | 39.45 | 19608861 | |
159 | Acetylation | SRDVFLPKPTWGNHT CCCCCCCCCCCCCCC | 58.17 | 19608861 | |
159 | Malonylation | SRDVFLPKPTWGNHT CCCCCCCCCCCCCCC | 58.17 | 26320211 | |
159 | Succinylation | SRDVFLPKPTWGNHT CCCCCCCCCCCCCCC | 58.17 | - | |
159 | Succinylation | SRDVFLPKPTWGNHT CCCCCCCCCCCCCCC | 58.17 | 27452117 | |
161 | Phosphorylation | DVFLPKPTWGNHTPI CCCCCCCCCCCCCCC | 52.72 | 28857561 | |
166 | Phosphorylation | KPTWGNHTPIFRDAG CCCCCCCCCCCCCCC | 23.29 | 28655764 | |
184 | Acetylation | QGYRYYDPKTCGFDF CCEEECCCCCCCCCC | 20.10 | - | |
185 | 2-Hydroxyisobutyrylation | GYRYYDPKTCGFDFT CEEECCCCCCCCCCC | 54.25 | - | |
185 | Acetylation | GYRYYDPKTCGFDFT CEEECCCCCCCCCCC | 54.25 | 23236377 | |
185 | Succinylation | GYRYYDPKTCGFDFT CEEECCCCCCCCCCC | 54.25 | - | |
185 | Succinylation | GYRYYDPKTCGFDFT CEEECCCCCCCCCCC | 54.25 | 27452117 | |
185 | Ubiquitination | GYRYYDPKTCGFDFT CEEECCCCCCCCCCC | 54.25 | 29967540 | |
187 | S-nitrosocysteine | RYYDPKTCGFDFTGA EECCCCCCCCCCCCC | 6.80 | - | |
187 | S-nitrosylation | RYYDPKTCGFDFTGA EECCCCCCCCCCCCC | 6.80 | 19483679 | |
191 | Acetylation | PKTCGFDFTGAVEDI CCCCCCCCCCCHHHH | 6.74 | - | |
191 | Acetylation | PKTCGFDFTGAVEDI CCCCCCCCCCCHHHH | 6.74 | 19608861 | |
191 | Ubiquitination | PKTCGFDFTGAVEDI CCCCCCCCCCCHHHH | 6.74 | 27667366 | |
199 | Phosphorylation | TGAVEDISKIPEQSV CCCHHHHHHCCHHHH | 36.53 | 21712546 | |
227 | Acetylation | DPRPEQWKEIATVVK CCCHHHHHHHHHHHH | 38.65 | 23954790 | |
227 | Malonylation | DPRPEQWKEIATVVK CCCHHHHHHHHHHHH | 38.65 | 26320211 | |
227 | Succinylation | DPRPEQWKEIATVVK CCCHHHHHHHHHHHH | 38.65 | - | |
227 | Succinylation | DPRPEQWKEIATVVK CCCHHHHHHHHHHHH | 38.65 | 27452117 | |
231 | Phosphorylation | EQWKEIATVVKKRNL HHHHHHHHHHHHCCH | 31.34 | 23312004 | |
234 | 2-Hydroxyisobutyrylation | KEIATVVKKRNLFAF HHHHHHHHHCCHHHH | 41.50 | - | |
234 | Acetylation | KEIATVVKKRNLFAF HHHHHHHHHCCHHHH | 41.50 | 19608861 | |
234 | Succinylation | KEIATVVKKRNLFAF HHHHHHHHHCCHHHH | 41.50 | 27452117 | |
234 | Ubiquitination | KEIATVVKKRNLFAF HHHHHHHHHCCHHHH | 41.50 | 19608861 | |
235 | Acetylation | EIATVVKKRNLFAFF HHHHHHHHCCHHHHH | 34.60 | 2402897 | |
253 | Acetylation | YQGFASGDGDKDAWA HCCCCCCCCCHHHHH | 60.67 | - | |
253 | Ubiquitination | YQGFASGDGDKDAWA HCCCCCCCCCHHHHH | 60.67 | - | |
253 | Acetylation | YQGFASGDGDKDAWA HCCCCCCCCCHHHHH | 60.67 | 19608861 | |
256 | Acetylation | FASGDGDKDAWAVRH CCCCCCCHHHHHHHH | 55.67 | 30582681 | |
259 | Ubiquitination | GDGDKDAWAVRHFIE CCCCHHHHHHHHHHH | 12.86 | 24816145 | |
276 | Phosphorylation | INVCLCQSYAKNMGL CCEEEEHHHHHHCCC | 26.51 | 28152594 | |
277 | Phosphorylation | NVCLCQSYAKNMGLY CEEEEHHHHHHCCCC | 8.84 | 28152594 | |
279 | N6-(pyridoxal phosphate)lysine | CLCQSYAKNMGLYGE EEEHHHHHHCCCCCC | 38.95 | - | |
279 | Acetylation | CLCQSYAKNMGLYGE EEEHHHHHHCCCCCC | 38.95 | - | |
279 | Other | CLCQSYAKNMGLYGE EEEHHHHHHCCCCCC | 38.95 | - | |
284 | Phosphorylation | YAKNMGLYGERVGAF HHHHCCCCCCEECEE | 15.94 | 27155012 | |
295 | Ubiquitination | VGAFTMVCKDADEAK ECEEEEEECCHHHHH | 1.99 | - | |
296 | 2-Hydroxyisobutyrylation | GAFTMVCKDADEAKR CEEEEEECCHHHHHH | 44.53 | - | |
296 | Acetylation | GAFTMVCKDADEAKR CEEEEEECCHHHHHH | 44.53 | 19608861 | |
296 | Malonylation | GAFTMVCKDADEAKR CEEEEEECCHHHHHH | 44.53 | 26320211 | |
296 | Succinylation | GAFTMVCKDADEAKR CEEEEEECCHHHHHH | 44.53 | - | |
296 | Succinylation | GAFTMVCKDADEAKR CEEEEEECCHHHHHH | 44.53 | 27452117 | |
296 | Ubiquitination | GAFTMVCKDADEAKR CEEEEEECCHHHHHH | 44.53 | 19608861 | |
302 | Acetylation | CKDADEAKRVESQLK ECCHHHHHHHHHHHH | 55.73 | 25038526 | |
302 | Malonylation | CKDADEAKRVESQLK ECCHHHHHHHHHHHH | 55.73 | 26320211 | |
302 | Ubiquitination | CKDADEAKRVESQLK ECCHHHHHHHHHHHH | 55.73 | 24816145 | |
306 | Phosphorylation | DEAKRVESQLKILIR HHHHHHHHHHHHHHC | 37.65 | 26437602 | |
309 | 2-Hydroxyisobutyrylation | KRVESQLKILIRPMY HHHHHHHHHHHCCCC | 28.03 | - | |
309 | Acetylation | KRVESQLKILIRPMY HHHHHHHHHHHCCCC | 28.03 | 20167786 | |
309 | Malonylation | KRVESQLKILIRPMY HHHHHHHHHHHCCCC | 28.03 | 26320211 | |
309 | Succinylation | KRVESQLKILIRPMY HHHHHHHHHHHCCCC | 28.03 | - | |
309 | Succinylation | KRVESQLKILIRPMY HHHHHHHHHHHCCCC | 28.03 | 27452117 | |
313 | Asymmetric dimethylarginine | SQLKILIRPMYSNPP HHHHHHHCCCCCCCC | 13.39 | - | |
313 | Methylation | SQLKILIRPMYSNPP HHHHHHHCCCCCCCC | 13.39 | - | |
315 | Sulfoxidation | LKILIRPMYSNPPLN HHHHHCCCCCCCCCC | 4.04 | 28183972 | |
316 | Phosphorylation | KILIRPMYSNPPLNG HHHHCCCCCCCCCCH | 14.15 | 22673903 | |
317 | Phosphorylation | ILIRPMYSNPPLNGA HHHCCCCCCCCCCHH | 36.29 | 22673903 | |
320 | Acetylation | RPMYSNPPLNGARIA CCCCCCCCCCHHHHH | 42.58 | - | |
320 | Ubiquitination | RPMYSNPPLNGARIA CCCCCCCCCCHHHHH | 42.58 | - | |
320 | Ubiquitination | RPMYSNPPLNGARIA CCCCCCCCCCHHHHH | 42.58 | 29967540 | |
333 | Phosphorylation | IAAAILNTPDLRKQW HHHHHHCCHHHHHHH | 18.09 | 30266825 | |
338 | 2-Hydroxyisobutyrylation | LNTPDLRKQWLQEVK HCCHHHHHHHHHHHH | 53.79 | - | |
338 | Acetylation | LNTPDLRKQWLQEVK HCCHHHHHHHHHHHH | 53.79 | 25825284 | |
338 | Malonylation | LNTPDLRKQWLQEVK HCCHHHHHHHHHHHH | 53.79 | 26320211 | |
338 | Succinylation | LNTPDLRKQWLQEVK HCCHHHHHHHHHHHH | 53.79 | - | |
338 | Succinylation | LNTPDLRKQWLQEVK HCCHHHHHHHHHHHH | 53.79 | 27452117 | |
338 | Ubiquitination | LNTPDLRKQWLQEVK HCCHHHHHHHHHHHH | 53.79 | - | |
345 | Acetylation | KQWLQEVKVMADRII HHHHHHHHHHHHHHH | 26.07 | 25038526 | |
353 | Ubiquitination | VMADRIIGMRTQLVS HHHHHHHHHHHHHHH | 9.35 | 21890473 | |
353 | Acetylation | VMADRIIGMRTQLVS HHHHHHHHHHHHHHH | 9.35 | - | |
353 | Ubiquitination | VMADRIIGMRTQLVS HHHHHHHHHHHHHHH | 9.35 | - | |
353 | Acetylation | VMADRIIGMRTQLVS HHHHHHHHHHHHHHH | 9.35 | 19608861 | |
353 | Ubiquitination | VMADRIIGMRTQLVS HHHHHHHHHHHHHHH | 9.35 | 21890473 | |
356 | Phosphorylation | DRIIGMRTQLVSNLK HHHHHHHHHHHHHHH | 19.84 | 26437602 | |
360 | Phosphorylation | GMRTQLVSNLKKEGS HHHHHHHHHHHHCCC | 45.07 | 23312004 | |
361 | Acetylation | MRTQLVSNLKKEGST HHHHHHHHHHHCCCC | 48.69 | - | |
361 | Acetylation | MRTQLVSNLKKEGST HHHHHHHHHHHCCCC | 48.69 | 19608861 | |
361 | Ubiquitination | MRTQLVSNLKKEGST HHHHHHHHHHHCCCC | 48.69 | 23000965 | |
363 | 2-Hydroxyisobutyrylation | TQLVSNLKKEGSTHN HHHHHHHHHCCCCCC | 53.69 | - | |
363 | Acetylation | TQLVSNLKKEGSTHN HHHHHHHHHCCCCCC | 53.69 | 23236377 | |
363 | Succinylation | TQLVSNLKKEGSTHN HHHHHHHHHCCCCCC | 53.69 | - | |
363 | Succinylation | TQLVSNLKKEGSTHN HHHHHHHHHCCCCCC | 53.69 | 27452117 | |
363 | Ubiquitination | TQLVSNLKKEGSTHN HHHHHHHHHCCCCCC | 53.69 | 29967540 | |
364 | Acetylation | QLVSNLKKEGSTHNW HHHHHHHHCCCCCCH | 71.16 | 25038526 | |
387 | Acetylation | MFCFTGLKPEQVERL CHHCCCCCHHHHHHH | 48.10 | 25038526 | |
396 | 2-Hydroxyisobutyrylation | EQVERLIKEFSIYMT HHHHHHHHHCEEEEE | 58.25 | - | |
396 | Acetylation | EQVERLIKEFSIYMT HHHHHHHHHCEEEEE | 58.25 | 19608861 | |
396 | Succinylation | EQVERLIKEFSIYMT HHHHHHHHHCEEEEE | 58.25 | - | |
396 | Succinylation | EQVERLIKEFSIYMT HHHHHHHHHCEEEEE | 58.25 | 19608861 | |
396 | Ubiquitination | EQVERLIKEFSIYMT HHHHHHHHHCEEEEE | 58.25 | 22817900 | |
399 | Phosphorylation | ERLIKEFSIYMTKDG HHHHHHCEEEEECCC | 17.57 | 27251275 | |
401 | Phosphorylation | LIKEFSIYMTKDGRI HHHHCEEEEECCCCE | 9.49 | 22817900 | |
404 | 2-Hydroxyisobutyrylation | EFSIYMTKDGRISVA HCEEEEECCCCEEEE | 41.47 | - | |
404 | Acetylation | EFSIYMTKDGRISVA HCEEEEECCCCEEEE | 41.47 | 19608861 | |
404 | Malonylation | EFSIYMTKDGRISVA HCEEEEECCCCEEEE | 41.47 | 26320211 | |
404 | Succinylation | EFSIYMTKDGRISVA HCEEEEECCCCEEEE | 41.47 | - | |
404 | Succinylation | EFSIYMTKDGRISVA HCEEEEECCCCEEEE | 41.47 | 27452117 | |
404 | Ubiquitination | EFSIYMTKDGRISVA HCEEEEECCCCEEEE | 41.47 | 23000965 | |
409 | Phosphorylation | MTKDGRISVAGVTSS EECCCCEEEEEECHH | 12.45 | 25072903 | |
414 | Phosphorylation | RISVAGVTSSNVGYL CEEEEEECHHHHHHH | 26.06 | 20068231 | |
415 | Phosphorylation | ISVAGVTSSNVGYLA EEEEEECHHHHHHHH | 19.94 | 28152594 | |
416 | Phosphorylation | SVAGVTSSNVGYLAH EEEEECHHHHHHHHH | 26.60 | 28152594 | |
420 | Phosphorylation | VTSSNVGYLAHAIHQ ECHHHHHHHHHHHHH | 9.09 | 28152594 | |
429 | Phosphorylation | AHAIHQVTK------ HHHHHHHCC------ | 25.19 | 28152594 | |
430 | Acetylation | HAIHQVTK------- HHHHHHCC------- | 60.53 | 155819 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AATM_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AATM_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AATM_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
THOC7_HUMAN | THOC7 | physical | 16169070 | |
HSP7C_HUMAN | HSPA8 | physical | 7559589 | |
KAT3_HUMAN | CCBL2 | physical | 26344197 | |
FAAA_HUMAN | FAH | physical | 26344197 | |
G6PI_HUMAN | GPI | physical | 26344197 | |
GLYG_HUMAN | GYG1 | physical | 26344197 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00128 | L-Aspartic Acid |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-73; LYS-90; LYS-150;LYS-159; LYS-234; LYS-296; LYS-396 AND LYS-404, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-96, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of HeLa cells using stable isotope labelingwith amino acids in cell culture (SILAC)."; Amanchy R., Kalume D.E., Iwahori A., Zhong J., Pandey A.; J. Proteome Res. 4:1661-1671(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-401, AND MASSSPECTROMETRY. |